第一单位:
Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.
作者:
Marco,Invernizzi [1]
;
Alessandro,de Sire [2]
;
Lorenzo,Lippi [1]
;
Konstantinos,Venetis [3]
;
Elham,Sajjadi [4]
;
Francesca,Gimigliano [5]
;
Alessandra,Gennari [6]
;
Carmen,Criscitiello [7]
;
Carlo,Cisari [8]
;
Nicola,Fusco [9]
作者单位:
Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.
[1]
Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.;Rehabilitation Unit, "Mons. L. Novarese" Hospital, Vercelli, Italy.
[2]
Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.;Ph.D. Program in Translational Medicine, University of Milan, Milan, Italy.
[3]
Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
[4]
Department of Mental and Physical Health and Preventive Medicine, University of Campania 'Luigi Vanvitelli', Napoli, Italy.
[5]
Division of Medical Oncology, University Hospital "Maggiore della Carità", Novara, Italy.
[6]
New Drugs and Early Drug Development for Innovative Therapies Division, IEO, European Institute of Oncology IRCCS, Milan, Italy.
[7]
Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.;Physical Medicine and Rehabilitation Unit, University Hospital "Maggiore della Carità", Novara, Italy.
[8]
Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.;Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
[9]
DOI
10.3389/fonc.2020.556718
PMID
33194622
发布时间
2023-11-12